Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care

Respir Med. 1998 Feb;92(2):351-3. doi: 10.1016/s0954-6111(98)90120-2.
No abstract available

MeSH terms

  • Androstadienes / economics
  • Androstadienes / therapeutic use*
  • Anti-Asthmatic Agents / economics
  • Anti-Asthmatic Agents / therapeutic use*
  • Anti-Inflammatory Agents / economics
  • Anti-Inflammatory Agents / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / economics
  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Fluticasone
  • Glucocorticoids / economics
  • Glucocorticoids / therapeutic use
  • Humans
  • Medical Audit*
  • Prednisolone / economics
  • Prednisolone / therapeutic use
  • Primary Health Care / economics*
  • Retrospective Studies
  • Statistics, Nonparametric
  • Treatment Outcome

Substances

  • Androstadienes
  • Anti-Asthmatic Agents
  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Prednisolone
  • Fluticasone